Ruan A - Search Results

1

Identification of the coexisting HER2 gene amplification and novel mutations in the HER2 protein-overexpressed mucinous epithelial ovarian cancer.

Lin WL, Kuo WH, Chen FL, Lee MY, Ruan A, Tyan YS, Hsu JD, Chiang H, Han CP. Lin WL, et al. Among authors: ruan a. Ann Surg Oncol. 2011 Aug;18(8):2388-94. doi: 10.1245/s10434-011-1572-z. Epub 2011 Feb 23. Ann Surg Oncol. 2011. PMID: 21347793

2

The HER2 gene copies per tumor cell either before or after correction for chromosome-17 correlated significantly with HER2 IHC results in epithelial ovarian cancer in a tissue microarray study.

Tsai WC, Lee MY, Chen FL, Wang PH, Lin WL, Ruan A, Li YJ, Wang SC, Chiang H, Han CP. Tsai WC, et al. Among authors: ruan a. Arch Gynecol Obstet. 2011 Sep;284(3):721-9. doi: 10.1007/s00404-010-1708-6. Epub 2010 Nov 3. Arch Gynecol Obstet. 2011. PMID: 21046136

3

HER2 gene amplification in primary mucinous ovarian cancer: a potential therapeutic target.

Han CP, Hsu JD, Yao CC, Lee MY, Ruan A, Tyan YS, Yang SF, Chiang H. Han CP, et al. Among authors: ruan a. Histopathology. 2010 Nov;57(5):763-4. doi: 10.1111/j.1365-2559.2010.03689.x. Histopathology. 2010. PMID: 21083606 No abstract available.

4

Assessing the impact of polysomy-17 on HER2 status and the correlations of HER2 status with prognostic variables (ER, PR, p53, Ki-67) in epithelial ovarian cancer: a tissue microarray study using immunohistochemistry and fluorescent in situ hybridization.

Lin CK, Lin WL, Chen FL, Lee MY, Kuo JF, Ruan A, Tyan YS, Chiang H, Chou MC, Han CP. Lin CK, et al. Among authors: ruan a. Int J Gynecol Pathol. 2011 Jul;30(4):372-9. doi: 10.1097/PGP.0b013e31820c9ff3. Int J Gynecol Pathol. 2011. PMID: 21623202

5

Assessment of HER2 Status Using Immunohistochemistry (IHC) and Fluorescence In Situ Hybridization (FISH) Techniques in Mucinous Epithelial Ovarian Cancer: A Comprehensive Comparison between ToGA Biopsy Method and ToGA Surgical Specimen Method.

Chao WR, Lee MY, Ruan A, Sheng HP, Hsu JD, Han CP, Koo CL. Chao WR, et al. Among authors: ruan a. PLoS One. 2015 Nov 13;10(11):e0142135. doi: 10.1371/journal.pone.0142135. eCollection 2015. PLoS One. 2015. PMID: 26566289 Free PMC article.

6

Scoring mechanisms of p16INK4a immunohistochemistry based on either independent nucleic stain or mixed cytoplasmic with nucleic expression can significantly signal to distinguish between endocervical and endometrial adenocarcinomas in a tissue microarray study.

Koo CL, Kok LF, Lee MY, Wu TS, Cheng YW, Hsu JD, Ruan A, Chao KC, Han CP. Koo CL, et al. Among authors: ruan a. J Transl Med. 2009 Apr 14;7:25. doi: 10.1186/1479-5876-7-25. J Transl Med. 2009. PMID: 19366452 Free PMC article.

7

Five commonly used markers (p53, TTF1, CK7, CK20, and CK34betaE12) are of no use in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray extension study.

Han CP, Kok LF, Lee MY, Wu TS, Ruan A, Cheng YW, Wang PH, Koo CL, Tyan YS. Han CP, et al. Among authors: ruan a. Arch Gynecol Obstet. 2010 Feb;281(2):317-23. doi: 10.1007/s00404-009-1115-z. Epub 2009 May 15. Arch Gynecol Obstet. 2010. PMID: 19444461

8

Adding the p16(INK4a) marker to the traditional 3-marker (ER/Vim/CEA) panel engenders no supplemental benefit in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray study.

Han CP, Lee MY, Kok LF, Ruan A, Wu TS, Cheng YW, Tyan YS, Lin CY. Han CP, et al. Among authors: ruan a. Int J Gynecol Pathol. 2009 Sep;28(5):489-96. doi: 10.1097/PGP.0b013e31819e8ab4. Int J Gynecol Pathol. 2009. PMID: 19696622

9

Multipoint Kras oncogene mutations potentially indicate mucinous carcinoma on the entire spectrum of mucinous ovarian neoplasms.

Lee YJ, Lee MY, Ruan A, Chen CK, Liu HP, Wang CJ, Chao WR, Han CP. Lee YJ, et al. Among authors: ruan a. Oncotarget. 2016 Dec 13;7(50):82097-82103. doi: 10.18632/oncotarget.13449. Oncotarget. 2016. PMID: 27888800 Free PMC article.

10

A promising hypothesis of c-KIT methylation/ expression paradox in c-KIT (+) squamous cell carcinoma of uterine cervix ----- CTCF transcriptional repressor regulates c-KIT proto-oncogene expression.

Chang SW, Chao WR, Ruan A, Wang PH, Lin JC, Han CP. Chang SW, et al. Among authors: ruan a. Diagn Pathol. 2015 Nov 25;10:207. doi: 10.1186/s13000-015-0438-2. Diagn Pathol. 2015. PMID: 26607501 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

80 results

Search Page